These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 21666912

  • 1. Multiplexed immunoassay for the rapid detection of anti-tumor-associated antigens antibodies.
    Desmet C, Le Goff GC, Brès JC, Rigal D, Blum LJ, Marquette CA.
    Analyst; 2011 Jul 21; 136(14):2918-24. PubMed ID: 21666912
    [Abstract] [Full Text] [Related]

  • 2. Enhancement of antibody detection in cancer using panel of recombinant tumor-associated antigens.
    Zhang JY, Casiano CA, Peng XX, Koziol JA, Chan EK, Tan EM.
    Cancer Epidemiol Biomarkers Prev; 2003 Feb 21; 12(2):136-43. PubMed ID: 12582023
    [Abstract] [Full Text] [Related]

  • 3. Improvement of protein immobilization for the elaboration of tumor-associated antigen microarrays: application to the sensitive and specific detection of tumor markers from breast cancer sera.
    Yang Z, Chevolot Y, Géhin T, Solassol J, Mange A, Souteyrand E, Laurenceau E.
    Biosens Bioelectron; 2013 Feb 15; 40(1):385-92. PubMed ID: 23017679
    [Abstract] [Full Text] [Related]

  • 4. Immunodiagnostic value of combined detection of autoantibodies to tumor-associated antigens as biomarkers in pancreatic cancer.
    Li J, Wang LJ, Ying X, Han SX, Bai E, Zhang Y, Zhu Q.
    Scand J Immunol; 2012 Mar 15; 75(3):342-9. PubMed ID: 22010875
    [Abstract] [Full Text] [Related]

  • 5. Autoantibody detection to tumor-associated antigens of P53, IMP1, P16, cyclin B1, P62, C-myc, Survivn, and Koc for the screening of high-risk subjects and early detection of esophageal squamous cell carcinoma.
    Zhou SL, Yue WB, Fan ZM, Du F, Liu BC, Li B, Han XN, Ku JW, Zhao XK, Zhang P, Cui J, Zhou FY, Zhang LQ, Fan XP, Zhou YF, Zhu LL, Liu HY, Wang LD.
    Dis Esophagus; 2014 Mar 15; 27(8):790-7. PubMed ID: 24147952
    [Abstract] [Full Text] [Related]

  • 6. Recursive partitioning as an approach to selection of immune markers for tumor diagnosis.
    Koziol JA, Zhang JY, Casiano CA, Peng XX, Shi FD, Feng AC, Chan EK, Tan EM.
    Clin Cancer Res; 2003 Nov 01; 9(14):5120-6. PubMed ID: 14613989
    [Abstract] [Full Text] [Related]

  • 7. Detection of autoantibodies to a panel of tumor-associated antigens for the diagnosis values of gastric cardia adenocarcinoma.
    Zhou SL, Ku JW, Fan ZM, Yue WB, Du F, Zhou YF, Liu YL, Li Y, Tang S, Hu YL, Hu XP, Hou ZC, Liu J, Liu Y, Feng XS, Wang LD.
    Dis Esophagus; 2015 Nov 01; 28(4):371-9. PubMed ID: 24612004
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of diagnostic value in using a panel of multiple tumor-associated antigens for immunodiagnosis of cancer.
    Wang P, Song C, Xie W, Ye H, Wang K, Dai L, Zhang Y, Zhang J.
    J Immunol Res; 2014 Nov 01; 2014():512540. PubMed ID: 24822225
    [Abstract] [Full Text] [Related]

  • 9. Real-Time, label-free monitoring of tumor antigen and serum antibody interactions.
    Campagnolo C, Meyers KJ, Ryan T, Atkinson RC, Chen YT, Scanlan MJ, Ritter G, Old LJ, Batt CA.
    J Biochem Biophys Methods; 2004 Nov 30; 61(3):283-98. PubMed ID: 15571777
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of tumour-associated antigen (TAA) miniarray in immunodiagnosis of colon cancer.
    Liu W, Wang P, Li Z, Xu W, Dai L, Wang K, Zhang J.
    Scand J Immunol; 2009 Jan 30; 69(1):57-63. PubMed ID: 19140877
    [Abstract] [Full Text] [Related]

  • 11. Humoral immune response to p16, a cyclin-dependent kinase inhibitor in human malignancies.
    Looi K, Megliorino R, Shi FD, Peng XX, Chen Y, Zhang JY.
    Oncol Rep; 2006 Nov 30; 16(5):1105-10. PubMed ID: 17016600
    [Abstract] [Full Text] [Related]

  • 12. Mini-array of multiple tumor-associated antigens (TAAs) in the immunodiagnosis of esophageal cancer.
    Qin JJ, Wang XR, Wang P, Ren PF, Shi JX, Zhang HF, Xia JF, Wang KJ, Song CH, Dai LP, Zhang JY.
    Asian Pac J Cancer Prev; 2014 Nov 30; 15(6):2635-40. PubMed ID: 24761876
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of a panel of tumor-associated antigens in breast cancer.
    Pagaza-Straffon C, Marchat LA, Herrera L, Díaz-Chávez J, Avante MG, Rodríguez YP, Arreola MC, López-Camarillo C.
    Cancer Biomark; 2020 Nov 30; 27(2):207-211. PubMed ID: 31839604
    [Abstract] [Full Text] [Related]

  • 14. A systematic review of humoral immune responses against tumor antigens.
    Reuschenbach M, von Knebel Doeberitz M, Wentzensen N.
    Cancer Immunol Immunother; 2009 Oct 30; 58(10):1535-44. PubMed ID: 19562338
    [Abstract] [Full Text] [Related]

  • 15. Autoantibodies to tailor-made panels of tumor-associated antigens in breast carcinoma.
    Piura E, Piura B.
    J Oncol; 2011 Oct 30; 2011():982425. PubMed ID: 21423545
    [Abstract] [Full Text] [Related]

  • 16. Detection of autoantibodies to multiple tumor-associated antigens (TAAs) in the immunodiagnosis of breast cancer.
    Liu W, De La Torre IG, Gutiérrez-Rivera MC, Wang B, Liu Y, Dai L, Qian W, Zhang JY.
    Tumour Biol; 2015 Feb 30; 36(2):1307-12. PubMed ID: 25355596
    [Abstract] [Full Text] [Related]

  • 17. Multiplexed protein analysis using antibody microarrays and label-based detection.
    Haab BB.
    Methods Mol Med; 2005 Feb 30; 114():183-94. PubMed ID: 16156104
    [Abstract] [Full Text] [Related]

  • 18. Sensitive Multiplexed Quantitative Analysis of Autoantibodies to Cancer Antigens with Chemically S-Cationized Full-Length and Water-Soluble Denatured Proteins.
    Futami J, Nonomura H, Kido M, Niidoi N, Fujieda N, Hosoi A, Fujita K, Mandai K, Atago Y, Kinoshita R, Honjo T, Matsushita H, Uenaka A, Nakayama E, Kakimi K.
    Bioconjug Chem; 2015 Oct 21; 26(10):2076-84. PubMed ID: 26355635
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of pre-existent immunity in patients with primary breast cancer: molecular and cellular assays to quantify antigen-specific T lymphocytes in peripheral blood mononuclear cells.
    Rentzsch C, Kayser S, Stumm S, Watermann I, Walter S, Stevanoviç S, Wallwiener D, Gückel B.
    Clin Cancer Res; 2003 Oct 01; 9(12):4376-86. PubMed ID: 14555509
    [Abstract] [Full Text] [Related]

  • 20. Preferential autoimmune response in prostate cancer to cyclin B1 in a panel of tumor-associated antigens.
    Dai L, Li J, Ortega R, Qian W, Casiano CA, Zhang JY.
    J Immunol Res; 2014 Oct 01; 2014():827827. PubMed ID: 24860838
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.